Kaposi Sarcoma Pipeline Report 2016 - Therapeutics Review of 7 Companies & Drug Profiles - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Kaposi Sarcoma - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Kaposi Sarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Kaposi Sarcoma and special features on late-stage and discontinued projects.

The report enhances decision-making capabilities and helps to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Kaposi Sarcoma Overview
  3. Therapeutics Development
  4. Pipeline Products for Kaposi Sarcoma - Overview
  5. Pipeline Products for Kaposi Sarcoma - Comparative Analysis
  6. Kaposi Sarcoma - Therapeutics under Development by Companies
  7. Kaposi Sarcoma - Therapeutics under Investigation by Universities/Institutes
  8. Kaposi Sarcoma Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Kaposi Sarcoma - Products under Development by Companies
  13. Kaposi Sarcoma - Products under Investigation by Universities/Institutes
  14. Kaposi Sarcoma - Companies Involved in Therapeutics Development
  • Aphios Corporation
  • AstraZeneca Plc
  • Biogenomics Limited
  • CytRx Corporation
  • Delenex Therapeutics AG
  • Tumorend, LLC
  • Vironika, LLC

For more information visit http://www.researchandmarkets.com/research/zdmldh/kaposi_sarcoma

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology Drugs